From the qPCR results, we observed that the FOXP3 mRNA expression levels were significantly reduced in RA patients (0.1 ± 0.03) than the controls (1.4 ± 0.4, t = 3.100, **p = 0.0056) (Figure 3C). This evidence concerns the gene FOXP3 and rheumatoid arthritis.